Zhang Jinfang, Wan Lixin, Dai Xiangpeng, Sun Yi, Wei Wenyi
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA.
Biochim Biophys Acta. 2014 Apr;1845(2):277-93. doi: 10.1016/j.bbcan.2014.02.001. Epub 2014 Feb 22.
The Anaphase Promoting Complex/Cyclosome (APC/C) is a multi-subunit E3 ubiquitin ligase that primarily governs cell cycle progression. APC/C is composed of at least 14 core subunits and recruits its substrates for ubiquitination via one of the two adaptor proteins, Cdc20 or Cdh1, in M or M/early G1 phase, respectively. Furthermore, recent studies have shed light on crucial functions for APC/C in maintaining genomic integrity, neuronal differentiation, cellular metabolism and tumorigenesis. To gain better insight into the in vivo physiological functions of APC/C in regulating various cellular processes, particularly development and tumorigenesis, a number of mouse models of APC/C core subunits, coactivators or inhibitors have been established and characterized. However, due to their essential role in cell cycle regulation, most of the germline knockout mice targeting the APC/C pathway are embryonic lethal, indicating the need for generating conditional knockout mouse models to assess the role in tumorigenesis for each APC/C signaling component in specific tissues. In this review, we will first provide a brief introduction of the ubiquitin-proteasome system (UPS) and the biochemical activities and cellular functions of the APC/C E3 ligase. We will then focus primarily on characterizing genetic mouse models used to understand the physiological roles of each APC/C signaling component in embryogenesis, cell proliferation, development and carcinogenesis. Finally, we discuss future research directions to further elucidate the physiological contributions of APC/C components during tumorigenesis and validate their potentials as a novel class of anti-cancer targets.
后期促进复合物/细胞周期体(APC/C)是一种多亚基E3泛素连接酶,主要调控细胞周期进程。APC/C由至少14个核心亚基组成,并分别在M期或M期/早G1期通过两种衔接蛋白之一Cdc20或Cdh1募集其底物进行泛素化。此外,最近的研究揭示了APC/C在维持基因组完整性、神经元分化、细胞代谢和肿瘤发生中的关键作用。为了更好地了解APC/C在调节各种细胞过程,特别是发育和肿瘤发生中的体内生理功能,已经建立并表征了许多APC/C核心亚基、共激活因子或抑制剂的小鼠模型。然而,由于它们在细胞周期调控中的重要作用,大多数靶向APC/C途径的种系敲除小鼠胚胎致死,这表明需要生成条件性敲除小鼠模型来评估每个APC/C信号成分在特定组织肿瘤发生中的作用。在这篇综述中,我们将首先简要介绍泛素-蛋白酶体系统(UPS)以及APC/C E3连接酶的生化活性和细胞功能。然后,我们将主要聚焦于表征用于理解每个APC/C信号成分在胚胎发生、细胞增殖、发育和致癌作用中生理作用的基因小鼠模型。最后,我们讨论未来的研究方向,以进一步阐明APC/C成分在肿瘤发生过程中的生理贡献,并验证它们作为一类新型抗癌靶点的潜力。